Yoram Braw
Overview
Explore the profile of Yoram Braw including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
495
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tilbor E, Hadar A, Portnoy V, Ganor O, Braw Y, Amital H, et al.
J Psychiatr Res
. 2023 Dec;
170:167-173.
PMID: 38150768
Background: Fibromyalgia Syndrome (FMS) is a highly prevalent condition, that causes chronic pain and severe reduction in quality of life and productivity, as well as social isolation. Despite the significant...
2.
Braw Y, Baruch A, Barboza M, Levin J, Poreh A
Appl Neuropsychol Adult
. 2023 Dec;
:1-8.
PMID: 38086391
Performance validity tests (PVTs) aim to detect noncredible performance during neuropsychological testing. Despite their established utility, their cognitively undemanding nature and format may unintentionally reveal their purpose, leading to ongoing...
3.
Mendlovic S, Bareket O, Kertzman S, Meree S, Goldman A, Hod R, et al.
Harefuah
. 2023 Sep;
162(8):481-486.
PMID: 37698325
Diagnosis of combat post-traumatic stress disorder (PTSD) is largely based on the subjective reports of the claimant and is therefore prone to over-diagnosis of symptoms. Over-diagnosis of combat PTSD is...
4.
Winter D, Braw Y
Health Psychol
. 2023 May;
42(5):335-342.
PMID: 37141019
Objective: The term "long-COVID" refers to the persistence of neurological symptoms after being ill with COVID-19 (e.g., headaches, fatigue, and attentional impairment). Providing information about long-COVID (i.e., "diagnosis threat") increased...
5.
Winter D, Braw Y
Appl Neuropsychol Adult
. 2022 Oct;
31(6):1365-1374.
PMID: 36201363
Background: The availability of information regarding neuropsychological tests threatens their confidentiality. This concern may be particularly relevant to Attention-Deficit/Hyperactivity Disorder (ADHD) considering its widespread online coverage. The present study explored...
6.
Winter D, Braw Y
J Atten Disord
. 2022 Jul;
26(14):1907-1913.
PMID: 35861241
Background: The current study aimed to validate the utility of previously established validity indicators derived from MOXO-d-CPT's continuous performance test. Method: Healthy simulators feigned impairment after searching online for relevant...
7.
Lev A, Elbaum T, Berger C, Braw Y
J Atten Disord
. 2021 Dec;
26(9):1212-1222.
PMID: 34911385
Objective: The current study assessed the utility of eye-movements measures, gathered while participants performed a commercially available Continuous Performance Test (CPT), to detect feigned ADHD-associated cognitive impairment. Method: Healthy simulators...
8.
Omer E, Braw Y
Brain Sci
. 2021 Aug;
11(8).
PMID: 34439658
Performance validity tests (PVTs) are used for the detection of noncredible performance in neuropsychological assessments. The aim of the study was to assess the efficacy (i.e., discrimination capacity) of a...
9.
Winter D, Braw Y
Int J Clin Health Psychol
. 2021 May;
22(1):100253.
PMID: 34054975
A subset of recovered COVID-19 patients report persistent neurological symptoms. These include non-specific symptoms (e.g., headaches and fatigue) which were found to be affected by psychological processes in other disorders...
10.
Braw Y
Neuropsychol Rev
. 2021 Apr;
32(1):71-98.
PMID: 33821424
Performance validity tests (PVTs) based on the forced-choice recognition memory (FCRM) paradigm are commonly used for the detection of noncredible performance. Examinees' response times (RTs) are affected by cognitive processes...